Yıl: 2022 Cilt: 47 Sayı: 3 Sayfa Aralığı: 1059 - 1066 Metin Dili: İngilizce DOI: 10.17826/cumj.1099652 İndeks Tarihi: 20-09-2022

Evaluation of physical and vital signs and the effect of carnosine in experimental hyperthyroidism

Öz:
Purpose: This study aims to investigate the effects of experimental hyperthyroidism and carnosine which is known to have antioxidant properties on physical and vital findings in rats, and to determine the relationship between these parameters and free T3 (FT3) levels. Materials and Methods: Rats were analyzed in 7 groups (each containing 12 animals); control (CONT), hyperthyroidism-1 (T:10-day L-thyroxine (L-T4) administration), hyperthyroidism-2 (T-T: 20-day L-T4 administration), Carnosine (10 day carnosine administration), Hyperthyroidism-1 + Carnosine (T-C), Hyperthyroidism-2 + Carnosine (T-TC), and Carnosine + Hyperthyroidism-1 (C-T). In order to create a hyperthyroidism model, L-thyroxine (L-T4) doses of 300 µg/kg rat weight/day and carnosine doses of 300 µg/kg rat weight/ day were intraperitoneally (ip) administered to the rats. Results: After 10 and 20 days of thyroxine administration, FT3 levels (T:3.640.51pg/mL, T-T: 4.060.91pg/mL) and body temperature (T:37.10.3oC, T-T: 37.60.3oC), significantly increased while body weight decreased (T:240.722.0g, T-T:263.028.7g). Carnosine administration only prevented the increase of FT3 levels, but had no effect on other parameters. Conclusion: The increased FT3 levels observed with L-T4 administration were consistent with the physical and vital findings, but carnosine administration did not reflect the expected effects on the physical findings observed in the hyperthyroid condition.
Anahtar Kelime: Hyperthyroidism body temperature heart weight body weight carnosine.

Deneysel hipertiroidide fiziksel ve vital bulguların ve karnozinin etkisinin değerlendirilmesi

Öz:
Amaç: Bu çalışmada, deneysel hipertiroidinin ve antioksidan özelliği bilinen karnozinin ratların fiziksel ve vital bulgular üzerine etkilerinin araştırılması; ve bu parametreler ile serbest T3 (FT3) seviyeleri arasındaki ilişkinin belirlenmesi amaçlandı. Gereç ve Yöntem: Ratlar; her biri 12 rattan oluşan (n=12) kontrol (CONT), hipertiroidi 1 (T), hipertiroidi 2 (T-T), Hipertiroidi-1 + Karnozin (T-C), Hipertiroidi-2 + Karnozin (T-TC), Karnozin (C) ve Karnozin + Hipertiroidi-1 (C-T) olmak üzere yedi gruba ayrıldı. Ratlarda hipertiroidi modeli oluşturmak için intraperitoneal (ip) olarak rat ağırlığı/gün başına 300 µg/kg L-tiroksin (L-T4) ve karnozinin etkilerinin belirlenmesi için rat ağırlığı/gün başına 300 µg/kg dozunda karnozin (ip) uygulandı. Bulgular: 10 ve 20 günlük tiroksin uygulaması ile FT3 düzeylerinin (T:3.640.51pg/mL, T-T: 4.060.91pg/mL) ve vücut sıcaklığının (T:37.10.3oC, T-T: 37.60.3oC) anlamlı şekilde arttığı, vücut ağırlığının (T:240.722.0g, T-T:263.028.7g) azaldığı tespit edildi. Karnozin uygulamasının etkileri incelendiğinde, sadece profilaktik uygulamada FT3 düzeylerinin yükselmesini engellediği, diğer parametreler üzerinde iyileştirici etkisinin olmadığı görüldü. Sonuç: L-T4 uygulamasıyla gözlenen artmış FT3 düzeylerinin elde edilen fiziksel ve vital bulgularla uyumlu olduğu ancak karnozin uygulamasının hipertiroidik tabloda gözlenen fiziksel bulgular üzerinde beklenen etkileri yansıtmadığı tespit edildi.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Mathew P, Rawla P. Hyperthyroidism. Treasure Island (FL), StatPearls Publishing; 2022.
  • 2. LiVolsi VA, Baloch ZW. The Pathology of hyperthyroidism. Front Endocrinol (Lausanne). 2018;9:737.
  • 3. Chi H, Chen S, Liao C, Liao C, Tsai M, Lin Y et al. Thyroid hormone receptors promote metastasis of human hepatoma cells via regulation of TRAIL. Cell Death Differ. 2012;19:1802–14.
  • 4. Sultana DR, Shahin AD, Md Jawadul H. Measurement of oxidative stress and total antioxidant capacity in hyperthyroid patients following treatment with carbimazole and antioxidant. Heliyon. 2021;8:e08651.
  • 5. Erdamar H, Demirci H, Yaman H, Erbil MK, Yakar T, Sancak B et al. The effect of hypothyroidism, hyperthyroidism, and their treatment on parameters of oxidative stress and antioxidant status. Clin Chem Lab Med. 2008;46:1004-10.
  • 6. Messarah M, Boumendjel A, Chouabia A, Klibet F, Abdennour C, Boulakoud MS et al. Influence of thyroid dysfunction on liver lipid peroxidation and antioxidant status in experimental rats. Exp Toxicol Pathol. 2010;62:301-10.
  • 7. Ghodsi R, Kheirouri S.Carnosine and advanced glycation end products: a systematic review. Amino Acids. 2018;50:1177-86.
  • 8. Venditti P, Di Meo S. Thyroid hormone- induced oxidative stress. Cell Mol Life Sci. 2006;63:414-34.
  • 9. Venditti P, Pamplona R, Portero-Otin M, De Rosa R, Di Meo S. Effect of experimental and cold exposure induced hyperthyroidism on H2O2 production and susceptibility to oxidative stress of rat liver mitochondria. Arch Biochem Biophys. 2006;447:11- 22.
  • 10. Venditti P, De Rosa R, Caldarone G, Di Meo S. Effect of prolonged exercise on oxidative damage and susceptibility to oxidants of rat tissues in severe hyperthyroidism. Arch Biochem Biophys. 2005;442:229-37.
  • 11. Moulakakis KG, Poulakou MV, Paraskevas KI, Dontas I, Vlachos IS, Sokolis DP et al. Hyperthyroidism is associated with increased aortic oxidative DNA damage in a rat model. In Vivo. 2007;21:1021-6.
  • 12. Huh K, Kwon TH, Kim JS, Park JM. Role of hepatic xanthine oxidase in thyroid dysfunction: Effect of thyroid hormones in oxidative stress in rat liver. Arch Pharm Res. 1998;21:236-40.
  • 13. Subudhi U, Das K, Paital B, Bhanja S, Chainy GB. Allevation of enhanced oxidative stres and oxygen consuption of L- thyroxine induced hyperthyroid rat liver mitocondria by vitamin E and curcumin. Chem Biol Interact. 2008;173:105-14.
  • 14. Romanque P, Cornejo P, Valdes S, Vidla LA. Thyroid hormone administration induces rat liver Nrf2 activation: Suppression by N-Acetylcysteine pretreatment. Thyroid. 2011;21:655-62.
  • 15. Zaninovich AA, Raices M, Rebagliati I, Ricci C, Hagmüller K. Brown fat thermogenesis in cold- acclimated rats is not abolished by the suppression of thyroid function. Am J Physiol Endocrinol Metab. 2002;283:E496-502.
  • 16. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001;344: 501- 9.
  • 17. Hwang JH, Kang SY, Kang AN, Jung HW, Jung C, Jeong JH et al. MOK, a pharmacopuncture medicine, regulates thyroid dysfunction in L-thyroxin-induced hyperthyroidism in rats through the regulation of oxidation and the TRPV1 ion channel. BMC Complement Altern Med. 2017;17:535.
  • 18. Artioli GG, Sale C, Jones RL. Carnosine in health and disease. Eur J Sport Sci. 2019;19:30-9.
  • 19. Razenkov I, Derwies G, Severin SZ. Zur Frage nach carnosin wirkung auf die magensaft sekretion. Physiol Chem. 1926;162:95-9.
  • 20. Mohamadin AM, Hammad LN, El-Bab MF, Abdel Gawad HS. Attenuation of oxidative stress in plasma and tissues of rats with experimentally induced hyperthyroidism by caffeic acid phenylethyl ester. Basic Clin Pharmacol Toxicol. 2007;100:84-90.
  • 21. Kim SM, Kim SC, Chung IK, Cheon WH, Ku SK. Antioxidant and protective effects of Bupleurum falcatum on the L- thyroxine- induced hyperthyroidism in rats. Evid Based Complement Alternat Med. 2012;2012:548497.
  • 22. Aragao CN, Souza LL, Cabanelas A, Oliveria KJ, Pazos- Moura CC. Effect of experimental hypo- and hyperthyroidism on serum adinopectin. Metabolism. 2007;56:6-11.
  • 23. Onur S, Haas V, Bosy-Westphal A, Hauer M, Paul T, Nutzinger D et al. Ltri-iodothyronine is a major determinant of resting energy expenditure in underweight patients with anorexia nervosa and during weight gain. Eur J Endocrinol. 2005;152:179– 84.
  • 24. Chiamolera MI, Wondisford FE. Thyrotropin- releasing hormone and the thyroid hormone feedback mechanism. Endocrinology. 2009;150:1091–6.
  • 25. Tanida M, Gotoh H, Taniguchi H, Otani H, Shen J, Nakamura T et al. Effects of central injection of L- carnosine on sympathetic nerve activity innervating brown adipose tissue and body temperature in rats. Regul Pept. 2007;144:62-71.
  • 26. Deng J, Zhao R, Zhang Z, Wang J. Changes in vasoreactivity of rat large- and medium-sized arteries induced by hyperthyroidism. Exp Toxicol Pathol. 2010;62:317-22.
  • 27. Fernandes RO, Dreher GJ, Schenkel PC, Fernandes TR, Ribeiro MF, Araujo AS et al. Redox status and pro-survival/pro-apoptotic protein expression in the early cardiac hypertrophy induced by experimental hyperthyroidism. Cell Biochem Funct. 2011;29:617- 23.
  • 28. Ghosh G, De K, Maity S, Bandyopadhyay D, Bhattacharya S, Reiter RJ et al. Melatonin protect against oxidative damage and restores expression of GLUT4 gene in the hyperthyroid rat heart. J Pineal Res. 2007;42:71-82.
  • 29. Heckmann M, Zimmer Hg. Effects of triiodothyronine in spontaneously hypertensive rats. Studies on cardiac metabolism, function, and heart weight. Basic Res Cardiol. 1992;87:333-43.
  • 30. Craig Ee, Chesley A, Hood Da. Thyroid hormone modifies mitochondrial phenotype by increasing protein import without altering degradation. Am J Physiol. 1998;275:C1508-15.
  • 31. Osuna PM, Udovcic M, Sharma MD. Hyperthyroidism and the heart. Methodist Debakey Cardiovasc J. 2017;13:60-3.
  • 32. Aldini G, Orioli M, Rossoni G, Savi F, Braidotti P, Vistoli G, et al. The carbonyl scavenger carnosine ameliorates dyslipidaemia and renal function in Zucker obese rats. J Cell Mol Med. 2011;15:1339-54.
APA DAĞLI F, Güntürk İ, SEYDEL G, YAZICI C (2022). Evaluation of physical and vital signs and the effect of carnosine in experimental hyperthyroidism. , 1059 - 1066. 10.17826/cumj.1099652
Chicago DAĞLI FATMA,Güntürk İnayet,SEYDEL GONUL SEYDA,YAZICI Cevat Evaluation of physical and vital signs and the effect of carnosine in experimental hyperthyroidism. (2022): 1059 - 1066. 10.17826/cumj.1099652
MLA DAĞLI FATMA,Güntürk İnayet,SEYDEL GONUL SEYDA,YAZICI Cevat Evaluation of physical and vital signs and the effect of carnosine in experimental hyperthyroidism. , 2022, ss.1059 - 1066. 10.17826/cumj.1099652
AMA DAĞLI F,Güntürk İ,SEYDEL G,YAZICI C Evaluation of physical and vital signs and the effect of carnosine in experimental hyperthyroidism. . 2022; 1059 - 1066. 10.17826/cumj.1099652
Vancouver DAĞLI F,Güntürk İ,SEYDEL G,YAZICI C Evaluation of physical and vital signs and the effect of carnosine in experimental hyperthyroidism. . 2022; 1059 - 1066. 10.17826/cumj.1099652
IEEE DAĞLI F,Güntürk İ,SEYDEL G,YAZICI C "Evaluation of physical and vital signs and the effect of carnosine in experimental hyperthyroidism." , ss.1059 - 1066, 2022. 10.17826/cumj.1099652
ISNAD DAĞLI, FATMA vd. "Evaluation of physical and vital signs and the effect of carnosine in experimental hyperthyroidism". (2022), 1059-1066. https://doi.org/10.17826/cumj.1099652
APA DAĞLI F, Güntürk İ, SEYDEL G, YAZICI C (2022). Evaluation of physical and vital signs and the effect of carnosine in experimental hyperthyroidism. Cukurova Medical Journal, 47(3), 1059 - 1066. 10.17826/cumj.1099652
Chicago DAĞLI FATMA,Güntürk İnayet,SEYDEL GONUL SEYDA,YAZICI Cevat Evaluation of physical and vital signs and the effect of carnosine in experimental hyperthyroidism. Cukurova Medical Journal 47, no.3 (2022): 1059 - 1066. 10.17826/cumj.1099652
MLA DAĞLI FATMA,Güntürk İnayet,SEYDEL GONUL SEYDA,YAZICI Cevat Evaluation of physical and vital signs and the effect of carnosine in experimental hyperthyroidism. Cukurova Medical Journal, vol.47, no.3, 2022, ss.1059 - 1066. 10.17826/cumj.1099652
AMA DAĞLI F,Güntürk İ,SEYDEL G,YAZICI C Evaluation of physical and vital signs and the effect of carnosine in experimental hyperthyroidism. Cukurova Medical Journal. 2022; 47(3): 1059 - 1066. 10.17826/cumj.1099652
Vancouver DAĞLI F,Güntürk İ,SEYDEL G,YAZICI C Evaluation of physical and vital signs and the effect of carnosine in experimental hyperthyroidism. Cukurova Medical Journal. 2022; 47(3): 1059 - 1066. 10.17826/cumj.1099652
IEEE DAĞLI F,Güntürk İ,SEYDEL G,YAZICI C "Evaluation of physical and vital signs and the effect of carnosine in experimental hyperthyroidism." Cukurova Medical Journal, 47, ss.1059 - 1066, 2022. 10.17826/cumj.1099652
ISNAD DAĞLI, FATMA vd. "Evaluation of physical and vital signs and the effect of carnosine in experimental hyperthyroidism". Cukurova Medical Journal 47/3 (2022), 1059-1066. https://doi.org/10.17826/cumj.1099652